Why Boeing (BA) Is Down 6.3% After Fresh 777X Delays And Supply Snags – And What's Next

Boeing recently came under renewed regulatory scrutiny that could push 777X certification into the late 2020s, while ongoing supply chain bottlenecks are constraining 737 MAX production and weighing on operations. At the same time, Boeing’s presence at the Farnborough Airshow with its MQ-28 Ghost Bat and 777X displays highlights its efforts to restore confidence and tap emerging autonomous defense opportunities despite these operational headwinds. We’ll now explore how renewed regulatory...

- Boeing recently came under renewed regulatory scrutiny that could push 777X certification into the late 2020s, while ongoing supply chain bottlenecks are constraining 737 MAX production and weighing on operations. - At the same time, Boeing's presence at the Farnborough Airshow with its MQ-28 Ghost Bat and 777X displays highlights its efforts to restore confidence and tap emerging autonomous defense opportunities despite these operational headwinds. - We'll now explore how renewed regulatory hurdles for the 777X reshape Boeing's existing investment narrative and the way investors assess its prospects.

Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. Boeing Investment Narrative Recap To own Boeing today, you generally have to believe the company can stabilize its commercial programs and gradually convert its large backlog into profitable, recurring cash flow. The latest 777X regulatory headwinds and 737 MAX supply issues cut close to that thesis, since the key near term catalyst remains production normalization while the biggest risk is still execution and certification delays.

This news directly reinforces that execution risk rather than introducing a new one. Against that backdrop, Boeing's plan to showcase the 777X and MQ-28 Ghost Bat at Farnborough is most relevant, because it puts the company's commercial flagship and emerging defense portfolio in front of customers and regulators at the same time its operational challenges are under scrutiny. For investors focused on catalysts, this pairing highlights both sides of the story: ongoing near term pressure from certification and supply constraints, and the potential longer term contribution from autonomous defense platforms.

Yet behind the airshow headlines, the renewed 777X scrutiny and still fragile 737 MAX supply chain are risks investors should be aware of as they consider whether... Boeing's narrative projects $125.6 billion revenue and $7.9 billion earnings by 2029. This requires 10.9% yearly revenue growth and a $6.0 billion earnings increase from $1.9 billion today.

Uncover how Boeing's forecasts yield a $270.00 fair value, a 24% upside to its current price. Exploring Other Perspectives The most optimistic analysts once expected Boeing to reach about US$133 billion in revenue and US$11.7 billion in earnings by 2028, but the latest 777X and 737 MAX setbacks show how far that view sits from the reality of continued certification and production risk, reminding you that analyst narratives can shift quickly and are worth revisiting against fresh news.